| Name | Title | Contact Details |
|---|
Arivale is a scientific wellness company that leverages cutting-edge research, personalized data and tailored coaching to help people optimize wellness and aid in avoiding disease. Arivale provides clients a scientific path to wellness based on their unique genetic makeup, characteristics, and lifestyle. Arivale is backed by leading scientists and investors with a strong track record in health, wellness, biotech breakthroughs and in building top-tier consumer brands.
Enara Health is building a data-driven platform and network to scale obesity treatment. Based in San Mateo, Calif., and operating since March 2015, Enara Health offers unique hybrid digital and in-person weight loss programs based on precision medicine. By combining mobile technology with health care visits and providing patients with personalized physician-driven medical weight loss programs, Enara Health routinely helps patients lose—and keep off—more than 15% of their baseline weight, which is far greater than the results seen with other m-health interventions.
AMRESCO is a Solon, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bay Area Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Marinette, WI. To find more information about Bay Area Medical Center, please visit www.bamc.org
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.